CURRENT GRANT RECIPIENTS
BY CATEGORY
Fellowships
Zaid Al-Kadhimi, MD; Beckman Research Institute of City of Hope , Duarte, CA
"Strategies to improve trafficking and activation of genetically modified T-cells"
Danelle James, MD; University of California, San Diego – Health Sciences, La Jolla, CA
"Targeting the CLL microenvironment – novel prognostic and therapeutic strategies"
Richard Jones, PhD; University of Texas, MD Anderson Cancer Center, Houston, TX
"Inhibiting the HDM-2 E3 ubiquitin ligase as a strategy against non-Hodgkin lymphoma"
Hudan Liu, PhD; The Trustees of the University of Pennsylvania, Philadelphia, PA
"Functional analysis of Notch transcriptional targets in T-ALL"
Prabodhika Mallikaratchy, PhD; Beckman Memorial Sloan-Kettering CancerCenter, New York, NY
"Multivalent DNA aptamer-based therapeutic agents for lymphoma"
Alice Nemajerova, PhD; The Research Foundation of SUNY-SUNY at Stony Brook, Stony Brook, NY
"The role of p73 in B-cell lymphomagenesis"
Patrick Ng, PhD; Stanford University School of Medicine, Stanford, CA
"Idiotype ScFv fusion protein vaccines for the Treatment of B-cell lymphoma"
Maria Corinna Palanca-Wessels, MD, PhD; Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA
"Optimizing delivery of short interfering RNA (siRNA) for the treatment of non-Hodgkin lymphoma"
Steven I. Park, MD; Formally Fred Hutchinson Cancer Research Center, Seattle, WA / Presently University of North Carolina, Chapel Hill, NC
"Pretargeted anti-CD20 radioimmunotherapy with streptavidin mutants-bisbiotin binding system"
Christian Steidl, MD; British Columbia Cancer Agency, Vancouver, BC
"Predicting treatment response in Hodgkin lymphoma by identifying new molecular markers"
Irina Velichutina, PhD; Albert Einstein College of Medicine, Bronx, NY
"PcG as a therapeutic target in diffuse large B-cell lymphomas"
Jing Yang, PhD; University of Texas, MD Anderson Cancer Center, Housteon, TX
"Targeting Beta2-microglobulin for induction of tumor apoptosis in mantle cell lymphoma"
Jing Zhou, MD, PhD; The Wistar Institute, Philadelphia, PA
"Mechanism of DNA replication and plasmid maintenance of epstein-barr virus (EBV)"
Clinical Investigator Career Development Awards
Joshua D. Brody, MD; Stanford University School of Medicine, Stanford, CA
"Dendritic cell-idiotype vaccine for mantle cell NHL after autologous stem cell transplant"
Kai Fu, MD, PhD; University of Nebraska Medical Center, Omaha, NE
"Targeting the miR-17-92 miRNA cluster for treatment of mantle cell lymphoma."
Damian J. Green, MD; Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA
"Optimizing radioimmunotherapy of lymphoma"
Brian Till, MD; Fred Hutchinson cancer Research Center, Seattle, WA
"Adoptive immunotherapy with CD20-specific T-cells for indolent and mantle cell lymphoma"
CLL-SLL Research Grant
David A. Frank, MD, PhD; Dana-Farber Cancer Institute, Boston, MA
"Targeted activation of STAT1 for the molecular therapy of chronic lymphomcytic leukemia"
David Frank, MD; Dana-Farber Cancer Institute, Boston, MA
"A Clinical Trial of STAT3 Inhibition in Patients with CLL"
Tracy M. Handel, PhD; University of California, San Diego, CA
"SDF1 in CLL survival and aggressiveness; interruption of signaling as a therapeutic strategy"
Thomas Kipps, MD; The Regents of the University of California, San Diego, CA
"Gene-Chemoimmunotherapy for Intractable Chronic Lymphocytic Leukemia"
Follicular Research Grant
Laurence J.N. Cooper, MD, PhD; MD Anderson Cancer Center, University of Texas, Houston, TX
"Second-generation trial for follicular lymphoma using CD19-specific T-cells"
Wing Chan, MD; University of Nebraska Medical Center, Omaha, NE
"Genetic abnormalities in follicular and transferred follicular lymphoma"
Randy Gascoyne, MD; BC Cancer Agency, Vancouver, BC
"Identification of biomarkers in follicular lymphoma"
Ari Melnick, MD; Joan & Sanford I. Weill Medical College of Cornell University, New York, NY
"BCL6 as a therapeutic target in Follicular Lymphoma"
Anne J. Novak, PhD; Mayo Clinic College of Medicine, Rochester, MN
"Biology and epidemiology of BlyS and APRIL in follicular lymphoma"
Mantle Cell Correlative Awards
Thomas M. Habermann, MD; Mayo Clinic College of Medicine, Rochester, MN
"Genetic predictors of prognosis in mantle cell lymphoma"
Ronald Levy, MD; Stanford University, Stanford, CA
"BCR signal transduction in mantle cell lymphoma patients receiving a Syk Kinase inhibitor"
Christiane Pott, MD; University Hospital Schleswig-Holstein, Kiel, Germany
"Minimal Residual Disease (MRD): Optimization and Validation of Quantification Techniques"
Geoffrey I. Shapiro, MD, PhD; Dana-Farber Cancer Institute, Boston, MA
"Pharmacodynamic studies of flavopiridol and PDO332991 in mantle cell lymphoma"
Wendy Stock, MD; The University of Chicago, Chicago, IL
"Strategies to eradicate minimal residual disease in mantle cell lymphoma"
Mantle Cell Awards
Robert Baiocchi, MD, PhD; The Ohio State University, Columbus, OH
"Targeting HDAC and protein arginine methyltransferase 5 enzymes in mantle cell lymphoma"
Steven H. Bernstein, MD; James P. Wilmot Cancer Center, University of Rochester, Rochester, NY
"Triterpenoids as novel therapeutic agents for the treatment of mantle cell lymphoma"
Joseph Bertino, MD; The Cancer Institute of New Jersey, New Brunswick, NJ
"Successful expansion of umbilical cord blood stem cells"
Tulin Budak-Alpdogan, MD and Joseph Bertino MD; The Cancer Institution of New Jersey, New Brunswick, NJ
"Post-transplant high dose MTX/ARA-C consolidation: A drug resistance gene transfer strategy for myeloprotection"
Sophie Dessureault, MD, PhD; H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL
"A phase one trial using a universal GM-CSF-producing and CD40L-expressing bystander cell line (GM.CD40L) in the formulation of autologous tumor cell-based vaccines for cancer patients with stage IV disease"
Martin Dreyling, MD, PhD; University Hospital Grosshadern/LMU, Munich, Germany
"European MCL network: Molecular targeted treatment options and individual patient risk factors"
Elliot Epner, MD, PhD; Formally Oregon Health and Science University, Portland, OR / Presently University of Pennsylvania, Hershey, PA
"Turning Cyclin D1 on and off in mantle cell lymphoma"
Michael Jensen, MD; City of Hope Medical Center, Duarte, CA
"Targeting minimal disease after autologous hematopoietic stem-cell transplant for mantle cell lymphoma by adoptive transfer of CD-19-specific T cells"
Ajay K. Gopal, MD; Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA
"Anti-CD45 radioimmunotherapy for mantle cell lymphoma"
Ajay K. Gopal, MD; The University of Washington, Seattle, WA
"High-dose radioimmunotherapy transplant conditioning regimens for relapsed or refractory MCL"
Timothy C. Greiner, MD; University of Nebraska Medical Center, Omaha, NE
"Methylation analysis in an international group of mantle cell lymphomas"
Pedro Jares, PhD; IDIBAPS, University of Barcelona, Barcelona, Spain
"Identification of tumor suppressor genes, epigenetic portrait, and genotyping of mantle cell lymphoma"
Shigeki Miyamoto, PhD; University of Wisconsin School of Medicine and Public Health, Madison, WI
"Targeting NF-kB activation mechanisms for MCL drug development"
Owen O'Connor, MD, PhD; Columbia University, New York, NY, 212-851-4701
"A translational approach for the discovery and evaluation of novel drugs for the treatment of mantle cell lymphoma"
Oliver W. Press, MD, PhD; Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA
"Optimizing adoptive T-cell immunotherapy for mantle cell lymphoma"
Leticia Quintanilla-Martinez, MD; Institute of Pathology, GSF Research Center for Environment and Health, Oberschleissheim, Germany
"Relevance of Cyclin D1 isoforms expression for the pathogenesis of mantle cell lymphoma (MCL)"
Louis M Staudt, MD, PhD; National Cancer Institute, Bethesda, MD
"Identification of therapeutic targets in mantle cell lymphoma using an RNA iInterference library screen" |
